Menu
ncarol.com
  • Home
  • Health
  • Real Estate
  • Business
  • Financial
  • Transportation
  • Books
  • Arts
  • Education
ncarol.com

FreezeNit Announces Exclusive Licensing of Novel Non-Toxic Lice Treatment Technology
ncarol.com/10291348

Trending...
  • Mysterious Interstellar Object 3I/ATLAS Appears to Pause Near Mars, Exhibiting Periodic Light Pulses
  • New Free Educational Bingo Cards Make Learning English Fun for First Graders
  • Mature Athlete - Want Elite, Web-Based Nutrition and Training Coaching?
FreezeNit
Naturally-Derived OTC Gel Eliminates Lice Without Neurotoxins, Launching Spring 2025

MARBLEHEAD, Mass. - ncarol.com -- FreezeNit, a leader in innovative lice treatment solutions, is thrilled to announce the exclusive licensing of a novel over-the-counter (OTC) lice treatment gel designed to provide a safe, naturally-derived, and highly effective alternative to traditional synthetic or pesticide-based lice treatments.

Unlike conventional OTC lice treatments that rely on pesticide-based pyrethroids, which have decreasing efficacy due to lice resistance, this new technology works by a purely mechanical method of action to eliminate lice and their eggs. The patented formula is free from harsh chemicals and instead leverages natural abrasives, such as diatomaceous earth and walnut shell powder, orange oil extract, and conditioning agents to physically shred lice and nits, while being gentle on the hair and scalp.

This addition strengthens FreezeNit's growing product portfolio, reinforcing the company's mission to provide clean, effective, science-backed treatments that parents can trust.

"This is an incredibly exciting milestone for FreezeNit," said Joanna Shu, CEO of FreezeNit. "By securing exclusive rights to this novel technology, we're positioned to be on the cutting edge of first aid treatments that are gentle on kids. Traditional lice treatments have failed parents and kids, but with this gel, lice don't stand a chance."

More on ncarol.com
  • CCHR Exposes Harms Behind Today's Mental Health Awareness Campaigns
  • Now Is the Right Time: Kaltra Highlights Its Proven Replacement Microchannel Coils
  • How to Optimize Your Website for AI Search with DeepRank AI
  • New Free Science Bingo Cards Help Grade 1 Students Learn Through Play
  • DeployHub Joins Catalyst Campus SDA TAP Lab

✔ Clinically Proven – was shown to be 96% effective in a clinical trial.
✔ No Resistance Issues – Unlike permethrin-based treatments, which have seen increased lice resistance, this technology works mechanically—not chemically—so lice cannot develop immunity.
✔ Patented & Protected – This novel formula and method of action is patented in the U.S., Canada, and the EU, ensuring exclusivity in the market.
✔ Class I, 510(k) Exempt – The FDA-regulated status allows for a fast-tracked market entry.

FreezeNit is actively engaging with retailers, distributors, and healthcare providers to bring this breakthrough lice treatment to families everywhere.

FreezeNit is an innovative healthcare company dedicated to revolutionizing first-aid with safe, effective, and science-backed solutions. By leveraging cutting-edge technology and natural alternatives to neurotoxins, FreezeNit provides families with fast, reliable, and pesticide-free treatments for head lice infestations.  For more information, visit www.FreezeNit.com.

Media Contact
Cathy Henry
cathy@freezenit.com
214-924-5992


Source: FreezeNit
Filed Under: Health

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Statement from the Campaign of Theodis Daniel, Republican for U.S. Congress (TX-18)
  • Divine Punk Announces Happy Christmas, a Holiday Soundscape by Rebecca Noelle
  • $430 Million 2026 Revenue Forecast; 26% Organic Growth; $500,000 Stock Dividend Highlight a Powerful AI & Digital Transformation Story: IQSTEL $IQST
  • Wzzph Deploys 5-Million-TPS Trading Engine with Hot-Cold Wallet Architecture Serving 500,000 Active Users Across Latin America
  • Preston Dermatology & Skin Surgery Center and Dr. Sheel Desai Solomon Dominate Raleigh's Best Awards from The News & Observer
  • $73.6 Million Multi-Year Backlog and Florida State Term Contract Drive Momentum for AI-Cybersecurity Pioneer: Cycurion, Inc. (N A S D A Q: CYCU) $CYCU
  • Year-Round Deals for Customers With Square Signs
  • SecurePII Raises US$3.5M (A$5M) to Unlock AI and Compliance for Voice Data and Expands Global Presence
  • Peter Coe Verbica Stands with Rural Families and Horse Owners: "Keep Horses Classified as Livestock"
  • The Mobile-First Company Raises $12M to Build Simple, Powerful Software for Small Teams
  • Lick Pineapple Flavored Massage Oil Outperforming and Enticing
  • Cerberus ODC in Collaboration with NVIDIA Launches All-American AI-RAN Stack, Enabling AI-Native 5G Today and Accelerating the Path to 6G
  • National Compliance Firm issues Artificial Intelligence Policy Program for Mortgage Banking
  • Pastor Darrell Armstrong Suspends Gubernatorial Campaign And Endorses Mikie Sherrill
  • Dr. Johnny Shanks Attends Full Arch Growth Conference 2025
  • Offline Asset Protection: NJTRX Implements 98 Percent Cold Storage as Industry Faces 2 Billion USD Losses
  • Thousands of Smiles, Millions of Logo Views: RoarFun Brings Emotions Into Premium Retail Spaces with Formula Simulator for Immersive Brand Activation
  • Qvarz LLC Expands Global Reach with High-Precision Quartz Cuvettes and Optical Components
  • $300 Million Web3 Initiative and ZIGChain Partnership Power $20 Target in Noble Capital Markets Report for SEGG Media (N A S D A Q: SEGG)
  • Assent Recognizes Manufacturers for Leading Supply Chain Sustainability Programs
_catLbl0 _catLbl1

Popular on ncarol.com

  • Mysterious Interstellar Object 3I/ATLAS Appears to Pause Near Mars, Exhibiting Periodic Light Pulses
  • New Free Educational Bingo Cards Make Learning English Fun for First Graders
  • Mature Athlete - Want Elite, Web-Based Nutrition and Training Coaching?
  • J French's #1 Album "I Don't Believe in Bad Days" Enters the Grammy Conversation
  • Heritage at South Brunswick's Townhome Models Coming Soon!
  • Root Canal Specialist In Frederick Maryland Joins Pearlfection Dentistry
  • Arc Longevity Sells Out Debut Women's Creatine Gummy
  • Rep. Gina H. Curry and Dr. Conan Tu Inspire at Kopp Foundation for Diabetes Hybrid Fundraising Gala and National Leadership Forum
  • Mullins McLeod Surges Into SC Governor's Race with $1.4 Million Raised in First Quarter; Most from His Own Commitment, Not Political Pockets
  • Multi-Signature Cold Storage: Keyanb Introduces Institutional-Grade Asset Protection for Chilean Crypto Traders

Similar on ncarol.com

  • A Dream Set Sail: How Grant a Dream™ Helped Lance Cruise Toward Joy
  • CCHR Exposes Harms Behind Today's Mental Health Awareness Campaigns
  • Veterans Day 2025: Virginia Veterans Can Claim Free Words of Veterans Book Vouchers
  • Parkchester Oral & Maxillofacial Surgery Celebrates 450+ 5-Star Reviews
  • Preston Dermatology & Skin Surgery Center and Dr. Sheel Desai Solomon Dominate Raleigh's Best Awards from The News & Observer
  • Year-Round Deals for Customers With Square Signs
  • Dr. Johnny Shanks Attends Full Arch Growth Conference 2025
  • Thousands of Smiles, Millions of Logo Views: RoarFun Brings Emotions Into Premium Retail Spaces with Formula Simulator for Immersive Brand Activation
  • Assent Recognizes Manufacturers for Leading Supply Chain Sustainability Programs
  • Arc Longevity Sells Out Debut Women's Creatine Gummy
Copyright © 2025 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute